Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2000-8-3
pubmed:abstractText
Marathon runners have an increased risk of developing joint disease. During and after a 42-km run, elevation of multiple cytokines occurs in the blood, reflecting inflammatory processes. We compared this cytokine response with serum levels of cartilage oligomeric matrix protein (COMP) and melanoma inhibitory activity (MIA), two markers for joint metabolism and/or damage.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1063-4584
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
222-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10806050-Adult, pubmed-meshheading:10806050-Arthritis, Rheumatoid, pubmed-meshheading:10806050-C-Reactive Protein, pubmed-meshheading:10806050-Case-Control Studies, pubmed-meshheading:10806050-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:10806050-Extracellular Matrix Proteins, pubmed-meshheading:10806050-Humans, pubmed-meshheading:10806050-Interleukin-1, pubmed-meshheading:10806050-Interleukin-6, pubmed-meshheading:10806050-Knee Injuries, pubmed-meshheading:10806050-Neoplasm Proteins, pubmed-meshheading:10806050-Osteoarthritis, pubmed-meshheading:10806050-Receptors, Interleukin-1, pubmed-meshheading:10806050-Receptors, Interleukin-6, pubmed-meshheading:10806050-Running, pubmed-meshheading:10806050-Time Factors, pubmed-meshheading:10806050-Tumor Necrosis Factor-alpha
pubmed:year
2000
pubmed:articleTitle
Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
pubmed:affiliation
Center for Experimental Rheumatology, University Hospital, Zürich, Switzerland. michel-neidhart@ruz.usz.ch
pubmed:publicationType
Journal Article, Comparative Study